SuspendedNot Applicable

Study of Minimally-invasive Ablative Renal Therapies (SMART) Registry

Stopped: Study is currently on hold.

Canada750 participantsStarted 2022-04-01

Plain-language summary

Multi-center prospective cohort study examining curative intent renal cryotherapy and radiofrequency ablation for small renal mass treatment in patients who are poor candidates for surgical resection, We will capture clinical, radiological, and pathological data as well as resource utilization (ex: time in hospital, ER visits), complications, and long-term functional and oncological outcomes. The investigators will also be biobanking blood and urine samples from participants for biological studies in the lab.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults with prior kidney tumor diagnosis; * Willing to permit provincial agencies (e.g Alberta Health Services, Alberta Health, Netcare, Service Alberta) to disclose health-related information to study; * Canadian and Albertan residents; * Signed informed consent. Exclusion Criteria: * Unwilling to participate in the study; * Unavailable for standard clinical urological care or follow-up in Alberta

What they're measuring

kidney cancer disease-specific survival

Timeframe: 5 years

Trial details

NCT IDNCT05210933

SponsorUniversity of Alberta

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Renal Cancer trials